Prospection is a healthcare data analytics product company with clients primarily in the Pharmaceutical industry.
Prospection uses predictive analytics and machine learning with real world healthcare data to unearth insights that help research, develop and target better healthcare outcomes for patients.
Prospection was founded in 2012 by Eric Chung, Peter Cronin and Ricky Chen. The company is headquartered in Haymarket, New South Wales, Australia.
Prospection creates proprietary software and algorithms to extract insights from “Real World Evidence” patient data sets, but also various other data sets such as pharmaceutical sales and CRM activity datasets.
Prospection's flagship product PharmDash, analyzes what drugs a patient’s taking, how they progress through different treatments, and how the drugs help them treat their disease. The other platform is PharmMap, which allows users to “integrate commercial and operational data to a single view using geospatial mapping algorithms."
Prospection has raised A$10M in a Series A round of funding on Feb 13, 2020. The investment was led by Main Sequence Ventures’ CSIRO Innovation Fund and Horizons Ventures.